Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings
- PMID: 18640909
- PMCID: PMC2607329
- DOI: 10.1098/rstb.2008.0100
Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings
Abstract
Gambling is a prevalent recreational behaviour. Approximately 5% of adults have been estimated to experience problems with gambling. The most severe form of gambling, pathological gambling (PG), is recognized as a mental health condition. Two alternate non-mutually exclusive conceptualizations of PG have considered it as an obsessive-compulsive spectrum disorder and a 'behavioural' addiction. The most appropriate conceptualization of PG has important theoretical and practical implications. Data suggest a closer relationship between PG and substance use disorders than exists between PG and obsessive-compulsive disorder. This paper will review data on the neurobiology of PG, consider its conceptualization as a behavioural addiction, discuss impulsivity as an underlying construct, and present new brain imaging findings investigating the neural correlates of craving states in PG as compared to those in cocaine dependence. Implications for prevention and treatment strategies will be discussed.
References
-
- American Psychiatric Association. American Psychiatric Association; Washington, DC: 1980. Diagnostic and statistical manual of mental disorders.
-
- Arnsten A.F. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J. Clin. Psychiatry. 2006;67(Suppl. 8):7–12. - PubMed
-
- Bechara A. Risky business: emotion, decision-making, and addiction. J. Gambl. Stud. 2003;19:23–51. doi:10.1023/A:1021223113233 - DOI - PubMed
-
- Belin D, Everitt B.J. Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron. 2008;57:432–441. doi:10.1016/j.neuron.2007.12.019 - DOI - PubMed
-
- Bergh C, Eklund T, Sodersten P, Nordin C. Altered dopamine function in pathological gambling. Psychol. Med. 1997;27:473–475. doi:10.1017/S0033291796003789 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01-DA020908/DA/NIDA NIH HHS/United States
- P50 AA015632/AA/NIAAA NIH HHS/United States
- UL1-RR024925/RR/NCRR NIH HHS/United States
- UL1 RR024925/RR/NCRR NIH HHS/United States
- RL1 AA017539/AA/NIAAA NIH HHS/United States
- P50 DA009241/DA/NIDA NIH HHS/United States
- P50DA16556/DA/NIDA NIH HHS/United States
- P50 DA016556/DA/NIDA NIH HHS/United States
- R01 DA019039/DA/NIDA NIH HHS/United States
- P50-AA015632/AA/NIAAA NIH HHS/United States
- P50-DA09241/DA/NIDA NIH HHS/United States
- P50-AA12870/AA/NIAAA NIH HHS/United States
- P50-DA016556/DA/NIDA NIH HHS/United States
- R01 DA020908/DA/NIDA NIH HHS/United States
- R01-DA019039/DA/NIDA NIH HHS/United States
- RL1-AA017539/AA/NIAAA NIH HHS/United States
- P50 AA012870/AA/NIAAA NIH HHS/United States